ValiRx plc (LON:VAL – Get Rating)’s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 12.23 ($0.15) and traded as high as GBX 18.85 ($0.23). ValiRx shares last traded at GBX 17.25 ($0.21), with a volume of 1,989,192 shares trading hands.
ValiRx Stock Performance
The firm has a market capitalization of £15.56 million and a PE ratio of -7.50. The company has a debt-to-equity ratio of 1.72, a quick ratio of 11.13 and a current ratio of 11.73. The company’s fifty day moving average price is GBX 12.23 and its two-hundred day moving average price is GBX 20.22.
ValiRx Company Profile
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Four Cheap Stocks With Interesting Insider Activity
- Can Health Drink Maker Celsius Outrun Its Monster Rival?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.